Gosta Tixell - Infimer Independent Director

INFR Stock  ILA 54.90  1.10  1.96%   

Director

Mr. Gosta Tixell serves as Independent Director at Infimer Ltd sice August 8, 2016. He is a member of the Audit, Compensation and Financial Statements Auditing committees. His work experience includes the following roles Chief Executive Officer and Chairman of the Board at Alhena Ltd., Independent Director at PlastoSac Ltd., External Director at Sunflower Sustainable Investments Ltd., Director at Taamal Mizra Electra, Director at ElectraKlaus Parking Solutions and Director at Enertec Systems Ltd. . He holds a Bachelors degree in International Relations from George Washington University and a MBA degree from INSEAD. since 2016.
Age 56
Tenure 8 years
Professional MarksMBA
Phone972 73 700 0266
Webhttp://www.infimer.com

Infimer Management Efficiency

The company has return on total asset (ROA) of (0.3287) % which means that it has lost $0.3287 on every $100 spent on assets. This is way below average. Infimer's management efficiency ratios could be used to measure how well Infimer manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Arie OrlevIsrael Discount Bank
70
Avraham ZeldmanMizrahi Tefahot
69
Hava ShapiraHarel Insurance Investments
62
Shmuel PinchasMigdal Insurance
73
Yaacov DanonMigdal Insurance
66
Israel EliahuMigdal Insurance
44
Yoav NardiBank Leumi Le Israel
72
Ohad MaraniBank Leumi Le Israel
63
Shlomo MiloMenora Miv Hld
72
Doron CohenHarel Insurance Investments
53
Ilan BiranIsrael Discount Bank
69
Zvi EphratMizrahi Tefahot
72
Ytzhak EdelmanBank Leumi Le Israel
67
David AvnerBank Leumi Le Israel
64
Moshe DovratBank Leumi Le Israel
69
Shulamit BandelClal Insurance Enterprises
61
Avital SteinMenora Miv Hld
53
Gideon SitermanMizrahi Tefahot
62
Joav NachshonMizrahi Tefahot
56
Ronit BodoMigdal Insurance
47
Dan SuesskindMigdal Insurance
70
Infimer Ltd develops technology and production processes for converting municipal solid waste. The company was founded in 2013 and is based in Avihayil, Israel. INFIMER operates under Waste Management classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 23700 people. Infimer (INFR) is traded on Tel Aviv Stock Exchange in Israel and employs 23,700 people.

Management Performance

Infimer Leadership Team

Elected by the shareholders, the Infimer's board of directors comprises two types of representatives: Infimer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Infimer. The board's role is to monitor Infimer's management team and ensure that shareholders' interests are well served. Infimer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Infimer's outside directors are responsible for providing unbiased perspectives on the board's policies.
Moshe Dayan, Chief Executive Officer
Asaf Tennenbaum, External Director
Shirley Behar, External Director
Hadas Gelander, External Director
Batya Many, Vice President - Finance
Tal Tamir, Director
Hadasa Gelander, External Director
Oren Zahavi, Vice President - Business Development
Eyal Ayalon, Director
Gosta Tixell, Independent Director
Avshalom Shilin, Director
Yuval Tamir, Chairman of the Board, CEO
Eli Zahavi, Director
Eliahu Zahavi, Director

Infimer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Infimer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infimer. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Infimer Stock analysis

When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Please note, there is a significant difference between Infimer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Infimer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infimer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.